top of page


The Strategic Imperative: Part 5 - TPP in Action: A Blueprint for Biotech and Forecasts
Welcome to the final installment of "The Strategic Imperative." We've journeyed through the Target Product Profile (TPP) , from...

Hi Ai Consulting
Jun 6, 20255 min read


The Strategic Imperative: Part 4 - TPP: Dosage, Administration, and Formulation
Welcome to Part 4 of "The Strategic Imperative." In our TPP journey, we've covered why it's important, how to define your product's...

Hi Ai Consulting
Jun 5, 20255 min read


The Strategic Imperative: Part 3 - Efficacy and Safety Endpoints in Your TPP
Welcome to Part 3 of "The Strategic Imperative," where we pivot from defining who your product is for to how it will perform and...

Hi Ai Consulting
Jun 4, 20254 min read


The Strategic Imperative: Part 2 - Defining Your TPP Indication and Patient Population
Welcome to Part 2 of "The Strategic Imperative," where we'll focus on the core of your Target Product Profile (TPP) : clearly defining...

Hi Ai Consulting
May 30, 20254 min read
The Strategic Imperative: Target Product Profile and Its Importance to Early Biotechs
Drive biotech success. Understand why a strategic Target Product Profile (TPP) is your essential roadmap for early-stage drug development, funding, and avoiding critical risks.

Hi Ai Consulting
May 28, 20254 min read


Biotech Disease and Market Assessments: Why Early Action is Crucial for Early Stage Biotechs
Early-stage biotech companies: initiate your commercial planning without delay. Proactive market analysis is crucial, regardless of immediate launch timelines. TheraAIsight enables you to navigate this critical phase effectively, providing essential insights into the evolving landscape.

Hi Ai Consulting
Apr 15, 20255 min read


Exploring Smart AI Investment Strategies for Biopharma in 2024
A quick read on getting started with AI in Biopharma

Hi Ai Consulting
Apr 15, 20244 min read
bottom of page